Merck cholesterol pill enlicitide and cancer therapy sac-TMT tapped for new priority program FDA expects Merck to submit applications in April and autumn of 2026, documents show Both drugs if approved ...
Sean is a JDM and off-road enthusiast of many years, and an automotive photographer. He holds a B.A. in Literature and Writing Studies, an A.A. in Communications, and an A.A. in English. He is ...
Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, BC / ACCESS Newswire / December 5, 2025 / Queue Ventures Ltd. ("Queue") is pleased to ...
Amazon Web Services is rolling out a slate of new homegrown AI models and a service for enterprise customers to build their own custom versions. The cloud provider launched Nova 2, a fleet of four new ...
The other day, my Uber driver shared something that stayed with me long after our ride. When I asked if she had children, she described her 18-year-old son, a “teddy bear” of a boy with severe, ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...
The paper addresses the challenge of scheduling multiple output priority queues of a switch in a real-world setting characterized by bursty traffic and diverse traffic priorities. Existing queue ...
Third Person Shooter 'We did not want to be close to them': The only game Arc Raiders wanted to avoid on release was predictably GTA 6, 'I don't think anyone wanted to be close to them' Third Person ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Commissioner Marty ...
The FDA has handed out the first nine national priority vouchers, positioning companies including Merck KGaA, Regeneron and Sanofi to complete the approval process in one to two months. FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results